Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family.

Authors: Schlingmann, KP  Weber, S  Peters, M  Niemann Nejsum, L  Vitzthum, H  Klingel, K  Kratz, M  Haddad, E  Ristoff, E  Dinour, D  Syrrou, M  Nielsen, S  Sassen, M  Waldegger, S  Seyberth, HW  Konrad, M 
Citation: Schlingmann KP, etal., Nat Genet. 2002 Jun;31(2):166-70. Epub 2002 May 28.
Pubmed: (View Article at PubMed) PMID:12032568
DOI: Full-text: DOI:10.1038/ng889

Magnesium is an essential ion involved in many biochemical and physiological processes. Homeostasis of magnesium levels is tightly regulated and depends on the balance between intestinal absorption and renal excretion. However, little is known about specific proteins mediating transepithelial magnesium transport. Using a positional candidate gene approach, we identified mutations in TRPM6 (also known as CHAK2), encoding TRPM6, in autosomal-recessive hypomagnesemia with secondary hypocalcemia (HSH, OMIM 602014), previously mapped to chromosome 9q22 (ref. 3). The TRPM6 protein is a new member of the long transient receptor potential channel (TRPM) family and is highly similar to TRPM7 (also known as TRP-PLIK), a bifunctional protein that combines calcium- and magnesium-permeable cation channel properties with protein kinase activity. TRPM6 is expressed in intestinal epithelia and kidney tubules. These findings indicate that TRPM6 is crucial for magnesium homeostasis and implicate a TRPM family member in human disease.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 1599669
Created: 2007-02-12
Species: All species
Last Modified: 2007-02-12
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.